Treatment with the investigational agent SEP-363856, a trace amine-associated receptor 1 (TAAR1) agonist with serotonin 5-HT1A agonist activity, yielded far fewer adverse events compared with atypical ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced data presentations on the late-stage pipeline candidate SEP-363856, a trace amine-associated receptor 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results